This week's ThreatsDay covers ransomware attacks, critical security flaws, credential theft, new malware, and sneaky tricks attackers use to break in.

Hackers are using GitHub-hosted PowerShell scripts and a WinRAR vulnerability to target government organizations across the Commonwealth ...

Windows 11 integriert Linux-Coreutils nativ in PowerShell und CMD. Administratoren profitieren von schnelleren Skripten ohne WSL-Umweg. Ein moderner Arbeitsplatz mit einem Monitor, auf dem komplexe ...

Offensive Security has announced the release of Kali Linux 2026.2, the second update for this year of their security-focused Linux distribution. The new version introduces nine additional tools, ...

Offensive Security shipped Kali Linux 2026.2 on Monday, June 29, delivering the most technically disciplined point release the project has produced in recent memory. The update hands penetration ...

Durante décadas, Windows y Linux representaron dos formas muy distintas de entender la informática. Windows dominó el escritorio con una experiencia gráfica, mientras Linux se consolidó en servidores, ...

Kali Linux 2026.1 is now available, introducing eight new tools, a kernel upgrade to version 6.18, a refresh of the annual theme, and a new BackTrack mode for the Kali-Undercover feature. The Kali ...

Kali Linux 2026.1, the first release of the year, is now available for download, featuring 8 new tools, a theme refresh, and a new BackTrack mode for Kali-Undercover. Kali is a Linux distribution ...

Penetration testers running Kali Linux have a new release to work with. Version 2026.1 delivers the annual theme refresh, a new BackTrack-inspired mode in kali-undercover, eight tools added to the ...

March 23 (Reuters) - Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi (SASY.PA), opens new tab to develop the privately held firm's experimental ...

Sanofi is no stranger to T-cell engagers, which remain a hot ticket for pharma dealmaking this year. (Photo by ALAIN JOCARD/AFP via Getty Images) Sanofi has returned to T-cell engager (TCE) territory ...